IP Library Granted Patent US 9,133,263
Granted Patent B2
US 9,133,263 · App. 12/743,395 · Granted Sep 15, 2015

Method for the separation of cells

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,133,263
App. No.
12/743,395
Granted
Sep 15, 2015
Kind
B2
Abstract

The invention relates to a cell containing a gene encoding a conditional transgenic surface marker that is detectable upon expression on the surface of the cell, wherein the gene encoding a conditional transgenic surface marker comprises: (i) a promoter, operably linked to (ii) a first transcription sequence, and (iii) a second transcription sequence encoding the surface marker, whereby the first transcription sequence prevents the transcription of the second transcription sequence, whereby the first transcription sequence is conditionally removable such that the second transcription sequence is transcribable, and whereby the surface marker renders the cell sortable through the detection of the conditional transgenic surface marker. Furthermore, the invention relates to a construct for generating such a cell, and to a method for separating such a cell from a population of cells.

Claims (25)

1. A cultured mammalian cell containing a gene encoding a conditionally expressed transgenic extracellular surface marker that is detectable on the surface of the cell and exhibits one or both of resistance to digestion with trypsin and non-internalization by the cell upon binding of an antibody, wherein the gene encoding a conditionally expressed transgenic surface marker comprises:

(i) a promoter for driving the transcription of a first transcription sequence, operably linked to

(ii) a said first transcription sequence for preventing transcription of a second transcription sequence, thereby avoiding an immune response against the cell, wherein the first transcription sequence is conditionally removable by a CRE recombinase or a FLP recombinase, and

(iii) a said second transcription sequence encoding the extracellular surface marker, comprising

(a) a transmembrane or membrane association domain that anchors the surface marker in the cell membrane wherein at least a portion of the surface marker is on the extracellular side of the cell membrane, and

(b) a tag sequence for rendering a cell sortable,

whereby the first transcription sequence is conditionally removable such that the second transcription sequence is transcribable, and

whereby the surface marker renders the cell sortable through the detection of the conditionally expressed transgenic surface marker on the extracellular surface of the cell.

2. The cell according to claim 1 , wherein the conditionally expressed transgenic extracellular surface marker is expressed ectopically as a modified form of an endogenously expressed protein, whereby the modified form of endogenously expressed protein does not fulfill the same function as the endogenously expressed protein.

3. The cell according to claim 1 , wherein the first transcription sequence is flanked on either side by a recombinase recognition site for conditional removal of the first transcription sequence from the gene, wherein the recombinase recognition sites flanking the first transcription sequence are the same.

4. The cell according to claim 1 , wherein the second transcription sequence is a gene from the group consisting of LNGFR, H2Kk, CD133, CD271, CD2, CD14, CD90, or CD45 in an unmodified or modified form.

5. The cell according to claim 1 , wherein the promoter is

a heterologous promoter,

a ubiquitous or tissue specific promoter, and/or

a constitutive or inducible promoter.

6. The cell according to claim 1 , wherein the promoter is a promoter of a gene from the group containing: actin, CAGGS, hCMV, PGK, FABP, Lck, CamKII, CD19, Keratin, Albumin, aP2, Insulin, MCK, MyHC, WAP, Col2A, Mx, tet, Trex, and ROSA26.

7. An isolated mammalian cell containing a gene encoding a conditionally expressed transgenic extracellular surface marker that is detectable on the surface of the cell and exhibits one or both of resistance to digestion with trypsin and non-internalization by the cell upon binding of an antibody, wherein the gene encoding a conditionally expressed transgenic surface marker comprises:

(i) a promoter for driving the transcription of a first transcription sequence, operably linked to

(ii) a said first transcription sequence for preventing transcription of a second transcription sequence, thereby avoiding an immune response against the cell, wherein the first transcription sequence is conditionally removable by a CRE recombinase or a FLP recombinase, and

(iii) a said second transcription sequence encoding the conditionally expressed extracellular surface marker,

comprising

(a) a transmembrane or membrane association domain that anchors the surface marker in the cell membrane wherein at least a portion of the surface marker is on the extracellular side of the cell membrane, and

(b) a tag sequence for rendering a cell sortable,

whereby the first transcription sequence is conditionally removable such that the second transcription sequence is transcribable, and

whereby the surface marker renders the cell sortable through the detection of the conditionally expressed transgenic surface marker on the surface of the cell.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 29, 2019
From: MILTENYI BIOTEC GMBH
To: MILTENYI BIOTEC B.V. & CO. KG
Reel/Frame 051443/0669 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 10, 2010
From: BOSIO, ANDREAS
To: MILTENYI BIOTEC GMBH
Reel/Frame 024811/0701 →